| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1782fde68e8711188a1881f5284fe0b0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
1992-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a6577357c69adb040ddbe9c97b15f5c |
| publicationDate |
1992-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9212430-A1 |
| titleOfInvention |
Prescreening of prostate cancer by serum prostatic specific antigen |
| abstract |
A method of prescreening for possible prostate cancer comprises measuring serum specific antigen (PSA) concentration and comparing that concentration to a specific threshold value to identify a subpopulation of men having a high risk of the presence of prostate cancer, thus suggesting more extensive diagnostic procedures to confirm or eliminate diagnosis of prostate cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0832105-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6030341-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9710842-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2703788-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6740516-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0049158-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5800347-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0049158-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5474903-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0832105-A1 |
| priorityDate |
1991-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |